175 related articles for article (PubMed ID: 21761354)
1. Treatment of recurrent endometrial stromal sarcoma with letrozole: a case report and literature review.
Sylvestre VT; Dunton CJ
Horm Cancer; 2010 Apr; 1(2):112-5. PubMed ID: 21761354
[TBL] [Abstract][Full Text] [Related]
2. Low-grade endometrial stromal sarcoma treated with the aromatase inhibitor letrozole.
Leunen M; Breugelmans M; De Sutter P; Bourgain C; Amy JJ
Gynecol Oncol; 2004 Dec; 95(3):769-71. PubMed ID: 15582003
[TBL] [Abstract][Full Text] [Related]
3. Recurrence of prolactin-producing endometrial stromal sarcoma with sex-cord stromal component treated with progestin and aromatase inhibitor.
Leiser AL; Hamid AM; Blanchard R
Gynecol Oncol; 2004 Aug; 94(2):567-71. PubMed ID: 15297205
[TBL] [Abstract][Full Text] [Related]
4. [Endometrial stromal sarcoma: complete response to therapy with aromatase-inhibitor, anastrozole].
Lisianskaia AS; Manikhas GM; Fadeeva EP; Fedosenko KV; Tapil'skaia NI
Vopr Onkol; 2010; 56(1):91-3. PubMed ID: 20361625
[No Abstract] [Full Text] [Related]
5. Long-Term Outcome of Aromatase Inhibitor Therapy With Letrozole in Patients With Advanced Low-Grade Endometrial Stromal Sarcoma.
Yamaguchi M; Erdenebaatar C; Saito F; Motohara T; Miyahara Y; Tashiro H; Katabuchi H
Int J Gynecol Cancer; 2015 Nov; 25(9):1645-51. PubMed ID: 26495759
[TBL] [Abstract][Full Text] [Related]
6. Endometrial stromal sarcoma: objective response to letrozole.
Maluf FC; Sabbatini P; Schwartz L; Xia J; Aghajanian C
Gynecol Oncol; 2001 Aug; 82(2):384-8. PubMed ID: 11531300
[TBL] [Abstract][Full Text] [Related]
7. Aromatase inhibitor therapy for endometrial stromal sarcoma - two-centre experience.
Serkies K; Abacjew-Chmyłko A; Wieczorek-Rutkowska M; Pęksa R
Ginekol Pol; 2018; 89(11):607-610. PubMed ID: 30508212
[TBL] [Abstract][Full Text] [Related]
8. [Pulmonary metastases from endometrial stromal sarcoma may benefit from hormone therapy].
Bréchot JM; Kamboucher M; Brauner M; Destable MD; Duperron F; Morère JF
Rev Mal Respir; 2007 Jan; 24(1):69-72. PubMed ID: 17268368
[TBL] [Abstract][Full Text] [Related]
9. Hormonal treatment with aromatase inhibitors for patients with endometrial stromal sarcoma.
Reich O; Regauer S
Gynecol Oncol; 2005 Jul; 98(1):173-4; author reply 174-5. PubMed ID: 15963815
[No Abstract] [Full Text] [Related]
10. Complete remission of advanced low-grade endometrial stromal sarcoma after aromatase inhibitor therapy: a case report.
Altal OF; Al Sharie AH; Halalsheh OM; Tashtush N; Shaban S; Alfaqih M; Aleshawi A
J Med Case Rep; 2021 May; 15(1):262. PubMed ID: 33947445
[TBL] [Abstract][Full Text] [Related]
11. Hormonal therapy with letrozole prior to surgical management of recurrent metastatic low-grade endometrial stromal sarcoma (LGESS).
Tzakas E; Liu S; Todd RW; Redman CW
J Obstet Gynaecol; 2009 Nov; 29(8):778-9. PubMed ID: 19821687
[No Abstract] [Full Text] [Related]
12. Aromatase inhibitor anastrozole as a second-line hormonal treatment to a recurrent low-grade endometrial stromal sarcoma: a case report.
Shoji K; Oda K; Nakagawa S; Kawana K; Yasugi T; Ikeda Y; Takazawa Y; Kozuma S; Taketani Y
Med Oncol; 2011 Sep; 28(3):771-4. PubMed ID: 20354812
[TBL] [Abstract][Full Text] [Related]
13. A Case of Metastatic Low-Grade Endometrial Stromal Sarcoma Treated with Letrozole after Ovarian Ablation by Radiotherapy.
Yang KH; Shin JA; Jung JH; Jung HW; Lee HR; Chang S; Park JY; Yi SY
Cancer Res Treat; 2015 Oct; 47(4):958-62. PubMed ID: 25715770
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of hormonal treatment for residual or recurrent low-grade endometrial stromal sarcoma. A retrospective study.
Dahhan T; Fons G; Buist MR; Ten Kate FJ; van der Velden J
Eur J Obstet Gynecol Reprod Biol; 2009 May; 144(1):80-4. PubMed ID: 19269732
[TBL] [Abstract][Full Text] [Related]
15. Hormonal therapy of endometrial stromal sarcoma.
Reich O; Regauer S
Curr Opin Oncol; 2007 Jul; 19(4):347-52. PubMed ID: 17545798
[TBL] [Abstract][Full Text] [Related]
16. Long-term disease-free survival after hormonal therapy of a patient with recurrent low grade endometrial stromal sarcoma: a case report.
Alkasi O; Meinhold-Heerlein I; Zaki R; Fasching P; Maass N; Jonat W; Beckmann MW
Arch Gynecol Obstet; 2009 Jan; 279(1):57-60. PubMed ID: 18379806
[TBL] [Abstract][Full Text] [Related]
17. Successful use of dydrogesterone as maintenance therapy in recurrent endometrial stromal sarcoma: a case report.
Akashi D; Todo Y; Shimada C; Okamoto K; Minobe S; Kato H
Jpn J Clin Oncol; 2013 Nov; 43(11):1145-9. PubMed ID: 24058200
[TBL] [Abstract][Full Text] [Related]
18. Uterine sarcoma and aromatase inhibitors: Tom Baker Cancer Centre experience and review of the literature.
Altman AD; Nelson GS; Chu P; Nation J; Ghatage P
Int J Gynecol Cancer; 2012 Jul; 22(6):1006-12. PubMed ID: 22740004
[TBL] [Abstract][Full Text] [Related]
19. Aromatase inhibition: a potential target for the management of recurrent or metastatic endometrial cancer by letrozole: more questions than answers?
Steed HL; Chu QS
Expert Opin Investig Drugs; 2011 May; 20(5):681-90. PubMed ID: 21413907
[TBL] [Abstract][Full Text] [Related]
20. Long-term survival in low-grade endometrial stromal sarcoma with childbirth and multidisciplinary treatment: a case report.
Maeda O; Moritani S; Ichihara S; Inoue T; Ishihara Y; Yamamoto S; Ito M; Matsumura Y; Sugiyama K; Horio M; Kondo I
J Med Case Rep; 2015 Oct; 9():233. PubMed ID: 26481040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
